137 filings
8-K
ATOS
Atossa Therapeutics Inc
18 Mar 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
8:35am
8-K
ATOS
Atossa Therapeutics Inc
12 Mar 24
Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors
8:30am
8-K
ATOS
Atossa Therapeutics Inc
13 Nov 23
Atossa Therapeutics Announces Third Quarter 2023 Financial Results and Provides Corporate Update
9:00am
8-K
ATOS
Atossa Therapeutics Inc
9 Nov 23
Departure of Directors or Certain Officers
9:00am
8-K
ATOS
Atossa Therapeutics Inc
6 Oct 23
Departure of Directors or Certain Officers
4:00pm
8-K
58q1 w1exqe4eix8p
28 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:28pm
8-K
t9ata7b
30 Aug 23
Other Events
8:41pm
8-K
w5w5mfxohil371qrn2i5
14 Aug 23
Atossa Therapeutics Announces Second Quarter 2023 Financial Results and Provides Corporate Update
8:30am
8-K
fop3zs3nh p28g
13 Jul 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:20pm
8-K
x8y2 mcudmg12
28 Jun 23
Atossa Therapeutics Announces $10M Stock Repurchase Program
9:01am
8-K
5d4e95h jgnh55d40x
23 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
9:00am
8-K
ni1wetc1 u4
1 Jun 23
Departure of Directors or Certain Officers
9:15am
8-K
44ao163b3fvl53wc
22 May 23
Changes in Registrant's Certifying Accountant
4:12pm
8-K
ltjyifco0 y54dbr9
15 May 23
Atossa Therapeutics Announces First Quarter 2023 Financial Results and Provides Corporate Update
9:10am
8-K
slmvrd cklgm278
4 May 23
Submission of Matters to a Vote of Security Holders
4:19pm
8-K
ib9zxoifics cejk76dl
26 Apr 23
Amendments to Articles of Incorporation or Bylaws
4:10pm
8-K
2uwmi9qkoh79vf9
4 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
11:38am
8-K
rejj75ie hx
22 Mar 23
Atossa Therapeutics Announces Year-End 2022 Financial Results and Provides Corporate Update
4:05pm
8-K
lnd 6gohr
13 Mar 23
Other Events
9:13am
8-K
u798mib
7 Nov 22
Atossa Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update
4:00pm